These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31130393)

  • 41. Evaluation of antimicrobial treatments in children with acute otitis media in Spain: a pharmacokinetic-pharmacodynamic (PK/PD) approach.
    Beobide I; Canut A; Gascón AR; Isla A; García-Rey C; De La Maza I; Labora A; Pedraz JL
    J Chemother; 2005 Dec; 17(6):628-35. PubMed ID: 16433193
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antimicrobial therapy for acute cholangitis: Tokyo Guidelines.
    Tanaka A; Takada T; Kawarada Y; Nimura Y; Yoshida M; Miura F; Hirota M; Wada K; Mayumi T; Gomi H; Solomkin JS; Strasberg SM; Pitt HA; Belghiti J; de Santibanes E; Padbury R; Chen MF; Belli G; Ker CG; Hilvano SC; Fan ST; Liau KH
    J Hepatobiliary Pancreat Surg; 2007; 14(1):59-67. PubMed ID: 17252298
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Simple Method for Measuring Adenosine Triphosphate in Acute Cholangitis Patients to Determine the Need for Emergency Biliary Drainage.
    Mishiro T; Kishimoto K; Hamamoto W; Cho Y; Mikami H; Ikuta Y; Yamashita N; Moriyama I; Ishimura N; Sato S; Ishihara S; Ishiguro S; Kinoshita Y
    Intern Med; 2019; 58(22):3213-3217. PubMed ID: 31735735
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endoscopic biliary drainage by nasobiliary drain or by stent placement in patients with acute cholangitis.
    Sharma BC; Kumar R; Agarwal N; Sarin SK
    Endoscopy; 2005 May; 37(5):439-43. PubMed ID: 15844022
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical use of ceftriaxone: a pharmacokinetic-pharmacodynamic perspective on the impact of minimum inhibitory concentration and serum protein binding.
    Perry TR; Schentag JJ
    Clin Pharmacokinet; 2001; 40(9):685-94. PubMed ID: 11605716
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitative assessment of severity of biliary tract infection.
    Krastev Z; Vladimirov B; Mateva L; Alexiev A
    Hepatogastroenterology; 1996; 43(10):792-5. PubMed ID: 8884291
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative activity of cefodizime and ceftriaxone against respiratory pathogens in an in vitro pharmacodynamic model simulating concentration-time curves.
    Blandino G; Milazzo I; Musumeci R; Nicolosi VM; Speciale A; Nicoletti G
    J Chemother; 2000 Dec; 12(6):503-8. PubMed ID: 11154034
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk factors of organ failure in cholangitis with bacteriobilia.
    Lee JM; Lee SH; Chung KH; Park JM; Lee BS; Paik WH; Park JK; Ryu JK; Kim YT
    World J Gastroenterol; 2015 Jun; 21(24):7506-13. PubMed ID: 26139997
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes in causative pathogens of acute cholangitis and their antimicrobial susceptibility over a period of 6 years.
    Kwon JS; Han J; Kim TW; Oh JH; Kwon HH; Jung JT; Kwon JG; Kim EY; Kim HG
    Korean J Gastroenterol; 2014 May; 63(5):299-307. PubMed ID: 24870302
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endoscopic biliary drainage for severe acute cholangitis.
    Lai EC; Mok FP; Tan ES; Lo CM; Fan ST; You KT; Wong J
    N Engl J Med; 1992 Jun; 326(24):1582-6. PubMed ID: 1584258
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The pharmacodynamic bases of the prescription of antimicrobials.
    Azanza Perea JR
    Rev Esp Quimioter; 2019 Sep; 32 Suppl 2(Suppl 2):35-37. PubMed ID: 31475808
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Sinusal penetration of amoxicillin-clavulanic acid. Formulation 1 g./125 mg., twice daily versus formulation 500 mg./125 mg., three times daily].
    Jehl F; Klossek JM; Peynegre R; Serrano E; Castillo L; Bobin S; Desprez D; Renault C; Neel V; Rouffiac E; Borie C
    Presse Med; 2002 Oct; 31(34):1596-603. PubMed ID: 12426976
    [TBL] [Abstract][Full Text] [Related]  

  • 53. How predictive is PK/PD for antibacterial agents?
    Frimodt-Møller N
    Int J Antimicrob Agents; 2002 Apr; 19(4):333-9. PubMed ID: 11978504
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microbiology and clinical characteristics of acute cholangitis with their impact on mortality; a retrospective cross sectional study.
    Akhtar F; Siddique MZ; Raza A; Mehmood S; Yusuf MA; Sultan F
    J Pak Med Assoc; 2020 Apr; 70(4):607-612. PubMed ID: 32296203
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics of ceftriaxone in patients undergoing continuous renal replacement therapy.
    Goto K; Sato Y; Yasuda N; Hidaka S; Suzuki Y; Tanaka R; Kaneko T; Nonoshita K; Itoh H
    J Basic Clin Physiol Pharmacol; 2016 Nov; 27(6):625-631. PubMed ID: 27497425
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Bacteriological, pharmacokinetic and clinical evaluations of ceftriaxone in the pediatric field. Pediatric study group of ceftriaxone].
    Fujii R; Meguro H; Arimasu O; Tagaya M; Fujita K; Sakata H; Yoshioka H; Maruyama S; Sanae N; Nagamatsu I
    Jpn J Antibiot; 1986 Aug; 39(8):1988-2008. PubMed ID: 3540338
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model.
    Hall Snyder A; Werth BJ; Barber KE; Sakoulas G; Rybak MJ
    J Antimicrob Chemother; 2014 Aug; 69(8):2148-54. PubMed ID: 24777900
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Explaining the poor bacteriologic eradication rate of single-dose ceftriaxone in group a streptococcal tonsillopharyngitis: a reverse engineering solution using pharmacodynamic modeling.
    Blumer JL; Reed MD; Kaplan EL; Drusano GL
    Pediatrics; 2005 Oct; 116(4):927-32. PubMed ID: 16199703
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Superiority of ceftriaxon to cefazolin in a rat model of obstructive jaundice: an experimental study.
    Reyhan E; Duman M; Demirci Y; Atici AE; Ozer M; Cevreli B; Ekiz F; Dalgic T; Akoglu M; Genc E
    J Invest Surg; 2013 Feb; 26(1):11-5. PubMed ID: 23273144
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Procalcitonin is a useful biomarker to predict severe acute cholangitis: a single-center prospective study.
    Umefune G; Kogure H; Hamada T; Isayama H; Ishigaki K; Takagi K; Akiyama D; Watanabe T; Takahara N; Mizuno S; Matsubara S; Yamamoto N; Nakai Y; Tada M; Koike K
    J Gastroenterol; 2017 Jun; 52(6):734-745. PubMed ID: 27783206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.